期刊文献+

临床生物样本的过程质量监控 被引量:2

The process quality control of clinical biological specimen
下载PDF
导出
摘要 样本质量已成为衡量样本库价值的主要指标。如何对生物样本进行质量控制是生物样本库建设的关键性难题。文章重点探讨医疗机构生物样本库如何通过制定和优化工作流程的管理措施来实现样本库的过程质量监控。获取样本产生过程中的关键信息,对事后样本评估是十分重要的。 Sample quality has become the main indicators of biobank value. Is the key problem of the construction of the biobank that how to carry on the quality control of biological samples . This mainly discusses how to develop and optimize the work flow management to achieve the process quality control in medical institutions biobank. The key information in the process of getting the sample is very important for the sample e-valuation after use.
出处 《临床和实验医学杂志》 2015年第21期1755-1757,共3页 Journal of Clinical and Experimental Medicine
基金 北京市科技计划项目(编号:D131100005313015) 国家科技重大专项"十二五"计划(编号:2013ZX10002004) 北京市科委科技计划重大项目(编号:D12110000391203) 北京市医院管理局临床医学发展专项(ZYLX201308)
关键词 生物样本质量 过程质量控制 质量评价 Specimen quality Process quality control Quality evaluation
  • 相关文献

参考文献7

  • 1胡颖,张连海,宋丽洁,王易雪,季加孚.生物样本质量的影响因素与评估[J].中国医药生物技术,2013,8(1):69-72. 被引量:15
  • 2International Society for Biological and Environmental Repositories. 2012 best practices for repositories - colletion, storage, retrieval, and distribution of biological materials for research. Biopreservation Biobanking[ J], 2012,10(2) :79 - 161.
  • 3刘克新,郑琳,王莹,赵秀梅,吉栩,江婧婧,郭渝成.生物样本库的现状及研究进展[J].中国病案,2014,15(9):32-34. 被引量:24
  • 4孙青,邓海峰,陆明洋,李敏,徐斌,郑晓,刘检,周怡,吴昌平,蒋敬庭.肿瘤生物样本资源库建立与管理的新策略[J].临床检验杂志,2014,32(1):45-47. 被引量:2
  • 5Nanni U, Betsou F, Rioudino S, et al. SPREC ware: software tools for Standard PREanalytical Code ( SPREC ) labeling - effective exchange and search of stored biospecimens [ J ]. Int J Biol Markers, 2012,27 ( 3 ) : e272 - e279.
  • 6Bernini P, Bertini I, Luchinat C, et al. Standard operating procedures for pre - analytical handling of blood and urine for metabolomic studies and biobanks[ J]. J Biomol NMR,2011,49(3 -4) :231 -243.
  • 7董哲君,肖飞,郭健.生物样本库建立现况及进展[J].中华检验医学杂志,2013,36(2):130-135. 被引量:27

二级参考文献73

  • 1陈仕林,程子敏.检验质量中不容忽视的分析前因素[J].检验医学与临床,2005,2(1):32-33. 被引量:7
  • 2季加孚.北京大学临床肿瘤学院标本库的建设[J].北京大学学报(医学版),2005,37(3):329-330. 被引量:81
  • 3孙磊.美国组织库事业发展情况[J].中国修复重建外科杂志,2006,20(11):1145-1146. 被引量:13
  • 4US Department of Health and Human Services, Food and Drug Administration. Challenge and opportunity on the critical path to new medical products [ EB/OL]. (2004-03-16). http://www. fda. gov/ScienceResearch/SpecialTopics/CriticalPathIntiative/Cri- ticalPathOpportunitiesReports/. UCM0771262. htm.
  • 5US Department of Health and Human Services, Food and Drug Administration. Critical path opportunities report [ EB/OL ]. (2006-03). http ://www. fda. gov/ScienceResearch/SpecialTopics/ CriticalPathIntiative/CriticalPathOpportunitiesReports/. UCM077- 254. pdf.
  • 6Vaught J, Rogers J, Myers K, et al. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr, 2011,42:1-7.
  • 7Vgv6ri , Welinder C, Lindberg H, et al. Biobank resources for future patient care:developments, principles and concepts. J Clin Bioinforma, 2011,1:24.
  • 8Merrero JA, Henley KS. The role of serum biomarkers in hepatocellular carcinoma surveillance. Gastroenterol Hepatol, 2011,7:821-823.
  • 9Franco JR, Simarro PP, Diarra A, et al. The human African trypanosomiasis specimen biobank: a necessary tool to support research of new diagnostics. PLoS Negl Trop Dis, 2012,6:e1571.
  • 10DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new esimates of drug development costs. J Health (NY) Econ, 2003,22 : 151-185.

共引文献53

同被引文献13

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部